Seth Klarman’s portfolio: Baupost Group 13F holdings

Quarterly SEC 13F-HR filingsCIK 0001061768Latest: Q2 2026

Q1 2015 filing in brief

In its Q1 2015 13F, filed May 15, 2015, Baupost Group reported $6.0B across 28 US positions. The largest: LNG (18.0%), VSAT (11.6%), EBAY (9.0%), MU (9.0%), PXDEUR (8.7%). In the quarter it opened 2 positions, sold out of 1, added to 9 and trimmed 1; positions opened and sold out came to 10.8% of the portfolio's value.

Methodology

Holdings come from the manager’s Form 13F-HR filings on SEC EDGAR, with amendments applied. Values and shares are reported at quarter-end; the filing date is when the report became public. These disclosures show reported long positions and listed options, not the manager’s entire portfolio or its trades since quarter-end.

Quarterly changes compare shares with the immediately preceding quarter on file. New and exited positions appear or disappear; added and trimmed positions change their share count by more than 1%. A share change can also reflect a stock split or other corporate action.

Opened and sold out is the value of new positions plus the prior value of exited positions, divided by the average of the two quarters’ reported portfolio values. It excludes changes to positions still held. Reported value growth includes price changes and is not a measure of investment performance. Largest-five and largest-ten weights exclude options.

Holdings

Filed May 15, 2015

  • 2 New
  • 9 Added
  • 1 Trimmed
  • 1 Exited

28 positions at March 31, 2015. Q/Q change compares shares with the preceding quarter.

RowTickerIssuerStatus
1LNGCHENIERE ENERGY INC$1.1B13.8M17.96%0.0%Held
2VSATVIASAT INC$687M11.5M11.55%0.0%Held
3EBAYEBAY INC$537M9.3M9.03%0.0%Held
4MUMICRON TECHNOLOGY INC$535M19.7M8.98%0.0%Held
5PXDEURPIONEER NAT RES CO$518M3.2M8.70%—New
6ARANTERO RES CORP$330M9.3M5.55%+19.1%Added
7—THERAVANCE INC$312M19.8M5.23%0.0%Held
8PBFPBF ENERGY INC$294M8.7M4.94%0.0%Held
9—KERYX BIOPHARMACEUTICALS INC$285M22.4M4.79%+22.3%Added
10—SUNEDISON SEMICONDUCTOR LTD$204M7.9M3.43%+90.5%Added
11ATRAGBXATARA BIOTHERAPEUTICS INC$193M4.8M3.24%+90.8%Added
12—FORWARD PHARMA A/S$152M5.4M2.55%0.0%Held
13—THERAVANCE BIOPHARMA INC$110M6.4M1.86%+5.0%Added
14VRTVEURVERITIV CORP$100M2.3M1.69%−1.7%Trimmed
15—CHIPMOS TECH BERMUDA LTD$81M3.3M1.36%0.0%Held
16—CITIGROUP INC$75M102.7M1.26%0.0%Held
17OCN2EUROCWEN FINL CORP$65M7.8M1.09%+31.3%Added
18NGNOVAGOLD RES INC$64M21.7M1.08%0.0%Held
19—KLX INC$58M1.5M0.97%—New
20—KOSMOS ENERGY LTD$57M7.2M0.96%0.0%Held
21PRTKEURPARATEK PHARMACEUTICALS INC$54M1.7M0.91%0.0%Held
22—BELLATRIX EXPLORATION LTD$53M21.8M0.89%+20.6%Added
23INVA 2.125 01/15/23THERAVANCE INC$41M48.2M0.69%+20.3%Added
24—AMERICAN INTL GROUP INC$27M1.3M0.46%+41.1%Added
25KIN1USDKINDRED BIOSCIENCES INC$22M3.0M0.36%0.0%Held
26ALDWUSDALON USA PARTNERS LP$17M954.2K0.29%0.0%Held
27—ALLIANCE ONE INTL INC$7M6.4M0.12%0.0%Held
28—NOVACOPPER INC$4M6.0M0.06%0.0%Held
1 exited position

Positions held in the preceding quarter and absent from this filing. Values and shares are from the preceding quarter.

TickerIssuerPrevious valuePrevious shares
—SYNERON MEDICAL LTD$23M2.4M
Every quarter on file (53)

From the manager’s Form 13F-HR filings on SEC EDGAR, amendments applied. Long US positions only; not a recommendation.